SUBJECTS
|
BROWSE
|
CAREER CENTER
|
POPULAR
|
JOIN
|
LOGIN
Business Skills
|
Soft Skills
|
Basic Literacy
|
Certifications
About
|
Help
|
Privacy
|
Terms
|
Email
Search
Test your basic knowledge |
USMLE/COMLEX Step 1 Pharmacology One Liners
Start Test
Study First
Subjects
:
health-sciences
,
usmle-step-1
,
comlex
Instructions:
Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can
study here
.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.
This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.
1. Agent used to treat MI and to reduce incidence of subsequent MI
Odansetron
L- thyroxine (T4)
Rhabdomyolysis and Hepatotoxicity
Aspirin - metoprolol
2. SSRI less likely to cause a withdrawal syndrome
Amoxapine
Fluoxetine
Bradycardia - SEXUAL DYSFUNCTION - decrease in HDL - and increase in Triglycerols (TG)
Gynecomastia
3. The fraction of administered dose of a drug that reaches systemic circulation
Sotalol
Bioavailability (F)
Morphine - methadone - meperidine - and fentanyl
Benztropine - trihexyphenidyl
4. Adenosine's MOA
Methadone - followed by slow dose reduction
Digoxin
Dolasetron
Activattion on an inward K+ current and inhibition of Ca++ current resulting in marked hyperpolarization
5. Indirect - Acting ACh Agonist - alcohol - short DOA and used in diagnosis of myasthenia gravis
Edrophonium
Acetazolamide
Adalimumab - infliximab and etanercept
Miosis and constipation
6. Treatment with cancer chemotherapy at high doses every 3-4 weeks - too toxic to be used continuously
Ganirelix
Probenecid and sulfinpyrazone
Rhabdomyolysis and Hepatotoxicity
Pulse therapy
7. SE of alpha blockers
Torsades de pointes
Decrease arterial blood pressure
Constipation - edema - and headache
Orthostatic hypotension (especially with first dose) and reflex tachycardia
8. MOA of class III antiarrhythmics
Potassium channel blockers
Nitrous oxide
Tamoxifen
Reduce inhibition - suppress anxiety - and produce relaxation
9. Usual time needed for full effect of antidepressant therapy
Pregnancy
100% O2 and hyperbaric O2
2 to 3 weeks
REM is decreased
10. Rapid acting insulins that do not self - aggregate
Enflurane and halothane
Point mutation
lispro insulin - aspart insulin - glulisine insulin
Clopidogrel and ticlopidine
11. Agents acting in the CNS or in the skeletal muscle - used to reduce abnormally elevated tone caused by neurologic or muscle end plate disease
Neutropenia and agranulocytosis
Amoxapine
Minoxidil
Spasmolytic drugs
12. Site of action of thiazide diuretics
Phenytoin
Work at early distal convoluted tubule
Phentolamine
Anti - inflammatory - analgesia - antipyretic and antiplatelet activity
13. Drug is used with testosterone for male fertility
Adenosine
Atropine - pralidoxime (2- PAM)
Leuprolide
PTU
14. Newer alpha 2 agonist (apraclonidine and brimonidine) treat glaucoma by acting to
Pioglitazone - Rosiglitazone - Troglitazone (withdrawn/d from market)
Alkylating agents (eg. - mechlorethamine - cyclophosphamide) - antibiotics (doxorubicin - daunorubicin) - cisplatin - nitrosourea
Inhibiting dihydroorotate dehydrogenase which leads to decreased pyrimidine synthesis - decreased T cell proliferation and decreased antibody production by B cells
Reduce aqueous secretion
15. Ultra long acting insulin - has over a day duration of action
Glargine (Lantus) - detemir
Nadolol
Benzodiazepine receptor BZ1 (although do not have a benzodiazepine ring structure)
Increasing sodium excretion and decreases arterial and venous tone
16. Newer atypical antipsychotic used for bipolar disorder - known to cause weight gain - and adversely affect diabetes
Fluphenazine and haloperidol
Odansetron - granisetron
Prednisone
Olanzapine
17. Agents for reduction of postpartum bleeding
Valproic acid
Cytomel
Neutro - leuko and thrombocytopenia
Oxytocin - ergonovine and ergotamine
18. MOA of Cardiac glycosides (eg. digoxin)
Gynecomastia hyperkalemia - and impotence
Indirectly increase intracellular calcium and cardiac contractility by inhibiting Na+/K+ ATPase
Acebutolol - atenolol - esmolol - metoprolol
high doses
19. Peptide drug used to treat CHF
Atracurium
Respiratory failure
Alprazolam and Clonazepam
Nesiritide (BNP)
20. Drug that selectively inhibits COX 2
Chlorpheniramine or cyclizine
Celecoxib and rofecoxib
Octreotide
Peripheral neuritis and hepatitis
21. MOA of general anesthetics
Amoxicillin
Flumazenil
Trazodone
Most are thought to act at GABA- A receptor - chloride channel
22. Activation of these receptors open K+ ion channels to cause membrane hyperpolarization
Cocaine
Postsynaptic Mu receptors
Adriamycin (doxorubicin) +bleomycin - vinblastine +dacarbazine
Pentoxifylline
23. Most inhaled anesthetics SE
Cardiac dysfunction - photosensitivity - skin (blue smurf syndrome) - Pulmonary fibrosis - thyroid and corneal deposits
Rheumatic disease
Methotrexate
Decrease arterial blood pressure
24. Except for these agents all SSRI have significant inhibition of CytP450 enzymes
Vitamin K and Fresh frozen plasma (FFP)
Citalopram and its metabolite escitalopram
Protease inhibitors
Edema - mild anemia; interaction with drugs that undergo CytP450 3A4 metabolism
25. Ability to bind reversibly to the same site as the drug and without activating the effector system
Efficacy
Lepirudin
Autocoids
Competitive antagonist
26. Cholinomimetics that increase outflow - open trabecular meshwork - and cause ciliary muscle contraction
Lepirudin
Warfarin (PT)
Amantadine
Pilocarpine - carbachol - physostigmine
27. Toxicities include nephrotoxicity and ototoxicity - leading to a severe interaction with aminoglycosides
Cisplatin
Esmolol
Diphenhydramine and cimetridine - respectively
L- dopa
28. Used intranasally and decreases bone resorption
Nifedipine
Impair absorption of fat soluble vitamin absorption (A - D - E - K)
Selegiline
Calcitonin (salmon prep)
29. The most important sign of withdrawal syndrome
Activattion on an inward K+ current and inhibition of Ca++ current resulting in marked hyperpolarization
Niacin
Dopamine blockade
Excessive CNS stimulation (seizures)
30. Used intravenously for acute arrhythmias during surgery
Esmolol
Urinary acidification and activated charcoal or continual nasogastric suction
Dimenhydrinate - meclizine - and other 1st generation
Pregnancy
31. Agents used in Huntington's Disease
Tetrabenazine (amine depleting drug) - Haloperidol (antipsychotic)
Ethinyl estradiol and mestranol
Autocoids
Temazpam - trizolam - flurazepam
32. TCA with greatest sedation of this group - and marked antimuscarinic effects - used for sleep
Tolerance
Adenosine
Doxepin
Propranolol
33. Antidepressant inhibiting norepinephrine - serotonin - and dopamine reuptake
SSRIs
Glucagon
Ethanol
Venlafaxine
34. Neurotoxicity with isoniazid (INH) prevented by
Arginine
Propofol
Administration of Vit. B6 (pyridoxine)
Reduce aqueous secretion
35. SE of ACE inhibitors
Platelet aggregation inhibition
Meperidine
Dry cough - hyperkalemia
Hyperuricemia - hypokalemia and ototoxicity
36. Nitrate used to prevent further attacks
Neuroleptanesthesia
Oral and transdermal forms of nitroglycerin
Activattion on an inward K+ current and inhibition of Ca++ current resulting in marked hyperpolarization
Flumazenil
37. Interferes with activity of T- lymphocytes
Hydroxychloroquine
Testicular cancer
Prednisone
Xanthine oxidase
38. The elimination of drug that occurs before it reaches the systemic circulation
Mannitol
First pass effect
Respiratory failure
Anti - inflammatory - analgesia - antipyretic and antiplatelet activity
39. Antidote used in poisonings: copper (Wilson's disease) - lead - mercury - and arsenic
L- dopa
Valproic acid - carbamazepine - phenytoin and gabapentin
Testicular cancer
Penicillamine
40. Angiotensin receptor blockers do Not cause
Warfarin (PT)
Chlorpheniramine or cyclizine
Dry cough
Meperidine
41. Window between therapeutic effect and toxic effect
Norepinephrine and serotonin
Halothane
Cevimeline
Therapeutic index
42. Diuretic used to antagonize aldosterone receptors
Spironolactone
Diethylstilbestrol (DES)
Disulfiram
Zafirlukast and montelukast
43. CCB with predominate effect on arteriole dilation
Flutamide (Eulexin)
L- thyroxine (T4)
Nifedipine
Acebutolol and atenolol
44. Patients being treated with lithium - who are dehydrated - or taking diuretics concurrently - could develop
Lithium toxicity
Clozapine
Cutaneous flush
Hydralazine
45. Only member of depolarizing neuromuscular blocker - causes fasciculation during induction and muscle pain after use; has short duration of action
Sulfonamides
Codeine - hydrocodone - and oxycodone
Norepinephrine and serotonin
Succinylcholine
46. Agent having no effect on D2 receptors - blocks D4 - reserved for resistant schizophrenia - and can cause fatal agranulocytosis
Epinephrine
Clozapine
Echothiophate
Sodium channel blockade
47. These agents increase cardiac output and may be beneficial in treatment of acute heart failure and some types of shock
Cocaine
Beta1 agonists
Naloxone (IV) - naltrexone (PO)
Nandrolone - oxymetholone - and oxandrolone
48. Drug increases the renal clearance hence decreases levels of lithium
Theophylline
Low - potency typical antipsychotics and clozapine
ORAL vancomycin
Carbamazepine
49. Cutaneous flush and be reduced by pretreatment with
IV and IM (only LMW)
Penicillamine
Aspirin
Selective inhibitor of microtubule assembly
50. Anti - psychotic not shown to cause tardive dyskinesia
Clozapine
Cyproheptadine
Dobutamine
Bioavailability (F)